| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 29,662 | 28,841 | 34,070 | 30,687 | | Cost of Revenue | 5,181 | 4,837 | 11,774 | 11,873 | | | Gross Profit | 24,481 | 24,004 | 22,296 | 18,814 | | | Operating Expenses | | Research Development | 11,728 | 11,197 | 14,275 | 15,296 | | Selling General and Administrative | 14,463 | 14,153 | 16,231 | 18,128 | | Non Recurring | 247 | 703 | 2,049 | 63,374 | | Others | 305 | 305 | 334 | 378 | | | | Total Operating Expenses | 26,743 | 26,358 | 32,889 | 97,176 | | | | Operating Income or Loss | (2,262) | (2,354) | (10,593) | (78,362) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 49 | (405) | (235) | 1,003 | | Earnings Before Interest And Taxes | (2,213) | (2,759) | (10,828) | (77,359) | | Interest Expense | 1,105 | 1,157 | 860 | 692 | | Income Before Tax | (3,318) | (3,916) | (11,688) | (78,051) | | Income Tax Expense | (7,662) | 396 | (2,177) | (628) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,344 | (4,312) | (9,511) | (77,423) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,344 | (4,312) | (9,511) | (77,423) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,344 | ($4,312) | ($9,511) | ($77,423) |
|
1.52% Nasdaq 0.00%
Income Statement
